top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
Anxiety disorders [[electronic resource] /] / edited by D.J. Nutt, J.C. Ballenger
Anxiety disorders [[electronic resource] /] / edited by D.J. Nutt, J.C. Ballenger
Pubbl/distr/stampa Malden, Mass., : Blackwell Science, 2003
Descrizione fisica 1 online resource (556 p.)
Disciplina 616.85/223061
616.85223
Altri autori (Persone) NuttDavid J. <1951->
BallengerJames C
Soggetto topico Anxiety
Soggetto genere / forma Electronic books.
ISBN 1-280-28482-X
9786610284825
0-470-70943-X
0-470-98683-2
0-470-98684-0
1-4051-2336-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Anxiety Disorders; Contents; Contributors; Preface; PART ONE: Introduction; 1. Conceptual Antecedents of the Anxiety Disorders; PART TWO: Symptoms and Syndromes; 2. Relationships Among Anxiety Disorders: Patterns and Implications; 3. Panic Disorder: Symptoms and Syndromes; 4. Generalized Anxiety Disorder; 5. Post-traumatic Stress Disorder; 6. Obsessive-compulsive Disorder; 7. Social Anxiety Disorder; 8. Sleep Aspects of Anxiety Disorders; 9. Childhood Antecedents of Adult Anxiety Disorders; 10. Anxiety and Schizophrenia; PART THREE: Mechanisms; 11. Neurochemical Aspects of Anxiety
12. Brain Imaging and Anxiety Disorders13. Genetic Dissection of Anxiety and Related Disorders; 14. Respiration and Anxiety; 15. Pharmacological Challenge Agents In Anxiety; 16. Panic Disorder and Medical Illness; PART FOUR: Treatments; 17. Benzodiazepines; 18. Selective Serotonin Reuptake Inhibitors in the Treatment of the Anxiety Disorders; 19. Treatment of Anxiety Disorders with Tricyclic Antidepressants; 20. Buspirone in the Treatment of Anxiety Disorders; 21. Antihistamines in the Treatment of Psychic and Somatic Anxiety States; 22. Anxiety Disorders: New Antidepressants
23. Cognitive Behavioral Treatment of Anxiety Disorders24. Exposure Therapy in the Treatment of Anxiety Disorders; 25. Anxiety Disorders: Alternative Drug Treatments; 26. Physical Treatments; 27. Herbal Therapy and Anxiety; PART FIVE: CONCLUSION; 28. Anxiety Disorders: Current Needs and Future Prospects; Index
Record Nr. UNINA-9910143505603321
Malden, Mass., : Blackwell Science, 2003
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anxiety disorders [[electronic resource] /] / edited by D.J. Nutt, J.C. Ballenger
Anxiety disorders [[electronic resource] /] / edited by D.J. Nutt, J.C. Ballenger
Pubbl/distr/stampa Malden, Mass., : Blackwell Science, 2003
Descrizione fisica 1 online resource (556 p.)
Disciplina 616.85/223061
616.85223
Altri autori (Persone) NuttDavid J. <1951->
BallengerJames C
Soggetto topico Anxiety
ISBN 1-280-28482-X
9786610284825
0-470-70943-X
0-470-98683-2
0-470-98684-0
1-4051-2336-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Anxiety Disorders; Contents; Contributors; Preface; PART ONE: Introduction; 1. Conceptual Antecedents of the Anxiety Disorders; PART TWO: Symptoms and Syndromes; 2. Relationships Among Anxiety Disorders: Patterns and Implications; 3. Panic Disorder: Symptoms and Syndromes; 4. Generalized Anxiety Disorder; 5. Post-traumatic Stress Disorder; 6. Obsessive-compulsive Disorder; 7. Social Anxiety Disorder; 8. Sleep Aspects of Anxiety Disorders; 9. Childhood Antecedents of Adult Anxiety Disorders; 10. Anxiety and Schizophrenia; PART THREE: Mechanisms; 11. Neurochemical Aspects of Anxiety
12. Brain Imaging and Anxiety Disorders13. Genetic Dissection of Anxiety and Related Disorders; 14. Respiration and Anxiety; 15. Pharmacological Challenge Agents In Anxiety; 16. Panic Disorder and Medical Illness; PART FOUR: Treatments; 17. Benzodiazepines; 18. Selective Serotonin Reuptake Inhibitors in the Treatment of the Anxiety Disorders; 19. Treatment of Anxiety Disorders with Tricyclic Antidepressants; 20. Buspirone in the Treatment of Anxiety Disorders; 21. Antihistamines in the Treatment of Psychic and Somatic Anxiety States; 22. Anxiety Disorders: New Antidepressants
23. Cognitive Behavioral Treatment of Anxiety Disorders24. Exposure Therapy in the Treatment of Anxiety Disorders; 25. Anxiety Disorders: Alternative Drug Treatments; 26. Physical Treatments; 27. Herbal Therapy and Anxiety; PART FIVE: CONCLUSION; 28. Anxiety Disorders: Current Needs and Future Prospects; Index
Record Nr. UNISA-996218167103316
Malden, Mass., : Blackwell Science, 2003
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Anxiety disorders [[electronic resource] /] / edited by D.J. Nutt, J.C. Ballenger
Anxiety disorders [[electronic resource] /] / edited by D.J. Nutt, J.C. Ballenger
Pubbl/distr/stampa Malden, Mass., : Blackwell Science, 2003
Descrizione fisica 1 online resource (556 p.)
Disciplina 616.85/223061
616.85223
Altri autori (Persone) NuttDavid J. <1951->
BallengerJames C
Soggetto topico Anxiety
ISBN 1-280-28482-X
9786610284825
0-470-70943-X
0-470-98683-2
0-470-98684-0
1-4051-2336-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Anxiety Disorders; Contents; Contributors; Preface; PART ONE: Introduction; 1. Conceptual Antecedents of the Anxiety Disorders; PART TWO: Symptoms and Syndromes; 2. Relationships Among Anxiety Disorders: Patterns and Implications; 3. Panic Disorder: Symptoms and Syndromes; 4. Generalized Anxiety Disorder; 5. Post-traumatic Stress Disorder; 6. Obsessive-compulsive Disorder; 7. Social Anxiety Disorder; 8. Sleep Aspects of Anxiety Disorders; 9. Childhood Antecedents of Adult Anxiety Disorders; 10. Anxiety and Schizophrenia; PART THREE: Mechanisms; 11. Neurochemical Aspects of Anxiety
12. Brain Imaging and Anxiety Disorders13. Genetic Dissection of Anxiety and Related Disorders; 14. Respiration and Anxiety; 15. Pharmacological Challenge Agents In Anxiety; 16. Panic Disorder and Medical Illness; PART FOUR: Treatments; 17. Benzodiazepines; 18. Selective Serotonin Reuptake Inhibitors in the Treatment of the Anxiety Disorders; 19. Treatment of Anxiety Disorders with Tricyclic Antidepressants; 20. Buspirone in the Treatment of Anxiety Disorders; 21. Antihistamines in the Treatment of Psychic and Somatic Anxiety States; 22. Anxiety Disorders: New Antidepressants
23. Cognitive Behavioral Treatment of Anxiety Disorders24. Exposure Therapy in the Treatment of Anxiety Disorders; 25. Anxiety Disorders: Alternative Drug Treatments; 26. Physical Treatments; 27. Herbal Therapy and Anxiety; PART FIVE: CONCLUSION; 28. Anxiety Disorders: Current Needs and Future Prospects; Index
Record Nr. UNINA-9910830050703321
Malden, Mass., : Blackwell Science, 2003
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anxiety disorders [[electronic resource] /] / edited by D.J. Nutt, J.C. Ballenger
Anxiety disorders [[electronic resource] /] / edited by D.J. Nutt, J.C. Ballenger
Pubbl/distr/stampa Malden, Mass., : Blackwell Science, 2003
Descrizione fisica 1 online resource (556 p.)
Disciplina 616.85/223061
616.85223
Altri autori (Persone) NuttDavid J. <1951->
BallengerJames C
Soggetto topico Anxiety
ISBN 1-280-28482-X
9786610284825
0-470-70943-X
0-470-98683-2
0-470-98684-0
1-4051-2336-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Anxiety Disorders; Contents; Contributors; Preface; PART ONE: Introduction; 1. Conceptual Antecedents of the Anxiety Disorders; PART TWO: Symptoms and Syndromes; 2. Relationships Among Anxiety Disorders: Patterns and Implications; 3. Panic Disorder: Symptoms and Syndromes; 4. Generalized Anxiety Disorder; 5. Post-traumatic Stress Disorder; 6. Obsessive-compulsive Disorder; 7. Social Anxiety Disorder; 8. Sleep Aspects of Anxiety Disorders; 9. Childhood Antecedents of Adult Anxiety Disorders; 10. Anxiety and Schizophrenia; PART THREE: Mechanisms; 11. Neurochemical Aspects of Anxiety
12. Brain Imaging and Anxiety Disorders13. Genetic Dissection of Anxiety and Related Disorders; 14. Respiration and Anxiety; 15. Pharmacological Challenge Agents In Anxiety; 16. Panic Disorder and Medical Illness; PART FOUR: Treatments; 17. Benzodiazepines; 18. Selective Serotonin Reuptake Inhibitors in the Treatment of the Anxiety Disorders; 19. Treatment of Anxiety Disorders with Tricyclic Antidepressants; 20. Buspirone in the Treatment of Anxiety Disorders; 21. Antihistamines in the Treatment of Psychic and Somatic Anxiety States; 22. Anxiety Disorders: New Antidepressants
23. Cognitive Behavioral Treatment of Anxiety Disorders24. Exposure Therapy in the Treatment of Anxiety Disorders; 25. Anxiety Disorders: Alternative Drug Treatments; 26. Physical Treatments; 27. Herbal Therapy and Anxiety; PART FIVE: CONCLUSION; 28. Anxiety Disorders: Current Needs and Future Prospects; Index
Record Nr. UNINA-9910841658803321
Malden, Mass., : Blackwell Science, 2003
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drugs and the future [[electronic resource] ] : brain science, addiction and society / / scientific coordinators, David Nutt ... [et al.]
Drugs and the future [[electronic resource] ] : brain science, addiction and society / / scientific coordinators, David Nutt ... [et al.]
Pubbl/distr/stampa London, : Elsevier/Academic, c2007
Descrizione fisica 1 online resource (615 p.)
Disciplina 362.29
Altri autori (Persone) NuttDavid J. <1951->
Soggetto topico Drug abuse
Drug abuse - Government policy
Drug addicts - Psychology
Drug addicts - Rehabilitation
Soggetto genere / forma Electronic books.
ISBN 1-280-74694-7
9786610746941
0-08-046774-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front cover; DRUGS AND THE FUTURE; Copyright page; Table of contents; Contributors; Foreword Drugs and the Future; Introduction; Acknowledgements; Chapter 1. Drugs Futures 2025; Chapter 2. Foresight; 1 INTRODUCTION; 2 WHAT IS FORESIGHT?; 3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE?; 4 WHAT HAPPENS NEXT?; Chapter 3. Neuroscience of Drugs and Addiction; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION; 4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION; 5 NEUROBIOLOGY OF RELAPSE
6 NEUROADAPTATIONS - INTRACELLULAR CASCADES7 VULNERABILITY TO ADDICTION; 8 HARMS CAUSED BY DRUGS OF ABUSE; 9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE; 10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION; 11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT; Chapter 4. Genomics; 1 EXECUTIVE SUMMARY; 2 GENES IN ACTION; 3 GENETIC ANALYSIS; 4 CURRENT STATE OF PLAY; 5 FUTURE DIRECTIONS IN RESEARCH; 6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY; 7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS
8 CONCLUSIONSChapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 SCIENTIFIC BASIS OF DRUG ADDICTION; 4 CURRENT PSYCHOACTIVE SUBSTANCES - EFFECTS AND HARMS; 5 INTERVENTIONS AND MANAGEMENT; 6 VISIONS FOR THE FUTURE - FUTURE CAPABILITIES AND APPLICATIONS; 7 CONCLUSIONS; Chapter 6. Pharmacology and Treatments; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 CURRENT PSYCHOACTIVE DRUGS; 5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS; 6 FUTURE PSYCHOACTIVE SUBSTANCES; 7 FUTURE THERAPEUTICS
8 CONTEXT OF FUTURE TREATMENTS9 PROSPECTS; 10 APPENDIX: ACRONYMS; Chapter 7. Psychological Treatments of Substance Misuse and Dependence; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS; 4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE?; 5 WHAT WILL BE THE DRUGS OF THE FUTURE?; 6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE; 7 PREVENTION STRATEGIES IN THE FUTURE?; 8 CONCLUSIONS; Chapter 8. Cognition Enhancers; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 BASIS OF LEARNING AND MEMORY
5 CURRENT COGNITION ENHANCERS6 COGNITION ENHANCERS IN DEVELOPMENT; 7 FUTURE COGNITION ENHANCERS; 8 IMPLICATIONS; 9 CONCLUSIONS; Chapter 9. Neuroimaging; 1 EXECUTIVE SUMMARY; 2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING; 3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION; 4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION; 5 MOLECULAR IMAGING AND THE ROLE OF PET; 6 ADVANCES IN MRI/S TECHNOLOGY; 7 TRANSCRANIAL MAGNETIC STIMULATION; 8 FURTHER DEVELOPMENTS; Chapter 10. Drug Testing; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 TEST MATRICES
4 ANALYTICAL METHODS
Record Nr. UNINA-9910458613803321
London, : Elsevier/Academic, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drugs and the future [[electronic resource] ] : brain science, addiction and society / / scientific coordinators, David Nutt ... [et al.]
Drugs and the future [[electronic resource] ] : brain science, addiction and society / / scientific coordinators, David Nutt ... [et al.]
Pubbl/distr/stampa London, : Elsevier/Academic, c2007
Descrizione fisica 1 online resource (615 p.)
Disciplina 362.29
Altri autori (Persone) NuttDavid J. <1951->
Soggetto topico Drug abuse
Drug abuse - Government policy
Drug addicts - Psychology
Drug addicts - Rehabilitation
ISBN 1-280-74694-7
9786610746941
0-08-046774-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front cover; DRUGS AND THE FUTURE; Copyright page; Table of contents; Contributors; Foreword Drugs and the Future; Introduction; Acknowledgements; Chapter 1. Drugs Futures 2025; Chapter 2. Foresight; 1 INTRODUCTION; 2 WHAT IS FORESIGHT?; 3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE?; 4 WHAT HAPPENS NEXT?; Chapter 3. Neuroscience of Drugs and Addiction; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION; 4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION; 5 NEUROBIOLOGY OF RELAPSE
6 NEUROADAPTATIONS - INTRACELLULAR CASCADES7 VULNERABILITY TO ADDICTION; 8 HARMS CAUSED BY DRUGS OF ABUSE; 9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE; 10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION; 11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT; Chapter 4. Genomics; 1 EXECUTIVE SUMMARY; 2 GENES IN ACTION; 3 GENETIC ANALYSIS; 4 CURRENT STATE OF PLAY; 5 FUTURE DIRECTIONS IN RESEARCH; 6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY; 7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS
8 CONCLUSIONSChapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 SCIENTIFIC BASIS OF DRUG ADDICTION; 4 CURRENT PSYCHOACTIVE SUBSTANCES - EFFECTS AND HARMS; 5 INTERVENTIONS AND MANAGEMENT; 6 VISIONS FOR THE FUTURE - FUTURE CAPABILITIES AND APPLICATIONS; 7 CONCLUSIONS; Chapter 6. Pharmacology and Treatments; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 CURRENT PSYCHOACTIVE DRUGS; 5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS; 6 FUTURE PSYCHOACTIVE SUBSTANCES; 7 FUTURE THERAPEUTICS
8 CONTEXT OF FUTURE TREATMENTS9 PROSPECTS; 10 APPENDIX: ACRONYMS; Chapter 7. Psychological Treatments of Substance Misuse and Dependence; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS; 4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE?; 5 WHAT WILL BE THE DRUGS OF THE FUTURE?; 6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE; 7 PREVENTION STRATEGIES IN THE FUTURE?; 8 CONCLUSIONS; Chapter 8. Cognition Enhancers; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 BASIS OF LEARNING AND MEMORY
5 CURRENT COGNITION ENHANCERS6 COGNITION ENHANCERS IN DEVELOPMENT; 7 FUTURE COGNITION ENHANCERS; 8 IMPLICATIONS; 9 CONCLUSIONS; Chapter 9. Neuroimaging; 1 EXECUTIVE SUMMARY; 2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING; 3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION; 4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION; 5 MOLECULAR IMAGING AND THE ROLE OF PET; 6 ADVANCES IN MRI/S TECHNOLOGY; 7 TRANSCRANIAL MAGNETIC STIMULATION; 8 FURTHER DEVELOPMENTS; Chapter 10. Drug Testing; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 TEST MATRICES
4 ANALYTICAL METHODS
Record Nr. UNINA-9910784655303321
London, : Elsevier/Academic, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drugs and the future [[electronic resource] ] : brain science, addiction and society / / scientific coordinators, David Nutt ... [et al.]
Drugs and the future [[electronic resource] ] : brain science, addiction and society / / scientific coordinators, David Nutt ... [et al.]
Edizione [1st ed.]
Pubbl/distr/stampa London, : Elsevier/Academic, c2007
Descrizione fisica 1 online resource (615 p.)
Disciplina 362.29
Altri autori (Persone) NuttDavid J. <1951->
Soggetto topico Drug abuse
Drug abuse - Government policy
Drug addicts - Psychology
Drug addicts - Rehabilitation
ISBN 1-280-74694-7
9786610746941
0-08-046774-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front cover; DRUGS AND THE FUTURE; Copyright page; Table of contents; Contributors; Foreword Drugs and the Future; Introduction; Acknowledgements; Chapter 1. Drugs Futures 2025; Chapter 2. Foresight; 1 INTRODUCTION; 2 WHAT IS FORESIGHT?; 3 WHAT APPROACH DID WE USE TO EXPLORE THE FUTURE OF DRUG USE?; 4 WHAT HAPPENS NEXT?; Chapter 3. Neuroscience of Drugs and Addiction; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 NEUROPSYCHOLOGY OF REINFORCEMENT LEARNING AND ADDICTION; 4 THE NEURAL SYSTEM BASIS OF REINFORCEMENT LEARNING: RELEVANCE TO NATURAL MOTIVATION AND DRUG ADDICTION; 5 NEUROBIOLOGY OF RELAPSE
6 NEUROADAPTATIONS - INTRACELLULAR CASCADES7 VULNERABILITY TO ADDICTION; 8 HARMS CAUSED BY DRUGS OF ABUSE; 9 DRUG ADDICTION: A SOCIAL COGNITIVE NEUROSCIENCE PERSPECTIVE; 10 THE MIND/BRAIN INTERFACE: NEUROBEHAVIOURAL ECONOMICS OF ADDICTION; 11 FUTURE IMPLICATIONS: NEW DRUGS, THEIR IMPACT AND MANAGEMENT; Chapter 4. Genomics; 1 EXECUTIVE SUMMARY; 2 GENES IN ACTION; 3 GENETIC ANALYSIS; 4 CURRENT STATE OF PLAY; 5 FUTURE DIRECTIONS IN RESEARCH; 6 THE IMPLICATIONS OF DEFINING GENETIC INFLUENCES IN DRUG USE FOR THE INDIVIDUAL AND SOCIETY; 7 THE BRAIN SCIENCE, ADDICTION AND DRUGS PROJECT QUESTIONS
8 CONCLUSIONSChapter 5. Experimental Psychology and Research into Brain Science, Addiction and Drugs; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 SCIENTIFIC BASIS OF DRUG ADDICTION; 4 CURRENT PSYCHOACTIVE SUBSTANCES - EFFECTS AND HARMS; 5 INTERVENTIONS AND MANAGEMENT; 6 VISIONS FOR THE FUTURE - FUTURE CAPABILITIES AND APPLICATIONS; 7 CONCLUSIONS; Chapter 6. Pharmacology and Treatments; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 CURRENT PSYCHOACTIVE DRUGS; 5 DRUG TREATMENTS FOR SUBSTANCE USE DISORDERS; 6 FUTURE PSYCHOACTIVE SUBSTANCES; 7 FUTURE THERAPEUTICS
8 CONTEXT OF FUTURE TREATMENTS9 PROSPECTS; 10 APPENDIX: ACRONYMS; Chapter 7. Psychological Treatments of Substance Misuse and Dependence; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 WHERE ARE WE NOW? THE CURRENT EVIDENCE BASE ON PSYCHOLOGICAL TREATMENTS; 4 PSYCHOLOGICAL TREATMENTS OF SUBSTANCE MISUSE AND DEPENDENCE: THE FUTURE?; 5 WHAT WILL BE THE DRUGS OF THE FUTURE?; 6 PSYCHOSOCIAL TREATMENTS OF THE FUTURE; 7 PREVENTION STRATEGIES IN THE FUTURE?; 8 CONCLUSIONS; Chapter 8. Cognition Enhancers; 1 EXECUTIVE SUMMARY; 2 DEFINITIONS AND SCOPE OF REVIEW; 3 BACKGROUND; 4 BASIS OF LEARNING AND MEMORY
5 CURRENT COGNITION ENHANCERS6 COGNITION ENHANCERS IN DEVELOPMENT; 7 FUTURE COGNITION ENHANCERS; 8 IMPLICATIONS; 9 CONCLUSIONS; Chapter 9. Neuroimaging; 1 EXECUTIVE SUMMARY; 2 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION: DEFINING PHARMACOLOGY AND CRAVING; 3 FUNCTIONAL NEUROIMAGING IN THE STUDY OF DRUG ADDICTION; 4 FUNCTIONAL NEUROIMAGING IN PRECLINICAL MODELS OF ADDICTION; 5 MOLECULAR IMAGING AND THE ROLE OF PET; 6 ADVANCES IN MRI/S TECHNOLOGY; 7 TRANSCRANIAL MAGNETIC STIMULATION; 8 FURTHER DEVELOPMENTS; Chapter 10. Drug Testing; 1 EXECUTIVE SUMMARY; 2 INTRODUCTION; 3 TEST MATRICES
4 ANALYTICAL METHODS
Record Nr. UNINA-9910808929803321
London, : Elsevier/Academic, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Sleep disorders [[electronic resource] /] / Sue Wilson, David Nutt
Sleep disorders [[electronic resource] /] / Sue Wilson, David Nutt
Autore Wilson Sue, Dr.
Pubbl/distr/stampa Oxford ; ; New York, : Oxford University Press, 2008
Descrizione fisica 1 online resource (140 p.)
Disciplina 616.8/498
Altri autori (Persone) NuttDavid J. <1951->
Collana Oxford psychiatry library
Soggetto topico Sleep disorders
Insomnia
Soggetto genere / forma Electronic books.
ISBN 1-283-57975-8
9786613892201
0-19-155288-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Contents; Preface; 1 Normal sleep; 2 Diagnosing sleep disorders; 3 Insomnia; 4 Hypersomnia; 5 Parasomnias; 6 Circadian rhythm sleep disorders; 7 Psychiatric disorders and sleep; 8 Sleep disorders associated with neurological and medical disorders; 9 Pharmacology of sleep; 10 Coping with irregular working hours: preventing sleep problems in junior doctors, nurses and other health professionals; 11 Appendix; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; Z
Record Nr. UNINA-9910452602503321
Wilson Sue, Dr.  
Oxford ; ; New York, : Oxford University Press, 2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Sleep disorders [[electronic resource] /] / Sue Wilson, David Nutt
Sleep disorders [[electronic resource] /] / Sue Wilson, David Nutt
Autore Wilson Sue, Dr.
Pubbl/distr/stampa Oxford ; ; New York, : Oxford University Press, 2008
Descrizione fisica 1 online resource (140 p.)
Disciplina 616.8/498
Altri autori (Persone) NuttDavid J. <1951->
Collana Oxford psychiatry library
Soggetto topico Sleep disorders
Insomnia
ISBN 1-283-57975-8
9786613892201
0-19-155288-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Contents; Preface; 1 Normal sleep; 2 Diagnosing sleep disorders; 3 Insomnia; 4 Hypersomnia; 5 Parasomnias; 6 Circadian rhythm sleep disorders; 7 Psychiatric disorders and sleep; 8 Sleep disorders associated with neurological and medical disorders; 9 Pharmacology of sleep; 10 Coping with irregular working hours: preventing sleep problems in junior doctors, nurses and other health professionals; 11 Appendix; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; Z
Record Nr. UNINA-9910779233903321
Wilson Sue, Dr.  
Oxford ; ; New York, : Oxford University Press, 2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Sleep disorders [[electronic resource] /] / Sue Wilson, David Nutt
Sleep disorders [[electronic resource] /] / Sue Wilson, David Nutt
Autore Wilson Sue, Dr.
Edizione [1st ed.]
Pubbl/distr/stampa Oxford ; ; New York, : Oxford University Press, 2008
Descrizione fisica 1 online resource (140 p.)
Disciplina 616.8/498
Altri autori (Persone) NuttDavid J. <1951->
Collana Oxford psychiatry library
Soggetto topico Sleep disorders
Insomnia
ISBN 1-283-57975-8
9786613892201
0-19-155288-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Contents; Preface; 1 Normal sleep; 2 Diagnosing sleep disorders; 3 Insomnia; 4 Hypersomnia; 5 Parasomnias; 6 Circadian rhythm sleep disorders; 7 Psychiatric disorders and sleep; 8 Sleep disorders associated with neurological and medical disorders; 9 Pharmacology of sleep; 10 Coping with irregular working hours: preventing sleep problems in junior doctors, nurses and other health professionals; 11 Appendix; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U; V; W; Z
Record Nr. UNINA-9910823822603321
Wilson Sue, Dr.  
Oxford ; ; New York, : Oxford University Press, 2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui